KPI 116 (Cytomel 25 mcg (0.025 mg))
Generic Name: liothyronine
Pill imprint KPI 116 has been identified as Cytomel 25 mcg (0.025 mg).
Cytomel is used in the treatment of hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test; myxedema; underactive thyroid (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Cytomel 25 mcg (0.025 mg) is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- KPI 116
- 25 mcg (0.025 mg)
- White / White
- 7.00 mm
- Prescription only
- Drug Class:
- Thyroid drugs
- Pregnancy Category:
- A - Studies show no risk
- CSA Schedule:
- Not a controlled drug
- King Pharmaceuticals Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|54569-2053||A-S Medication Solutions, LLC (repackager)|
|54868-1750||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Cytomel (liothyronine)
- Other brands: Triostat
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.